I am filled with determination and renewed purpose as I write this message. I’m proud of the incredible progress we’ve made together in 2023 toward conquering childhood cancer, and I am focused on the challenges that still lie ahead.

The field of childhood cancer has been one fraught with challenges. For smaller organizations like ours, those challenges require us to learn to punch above our weight class just to be seen and heard. Despite facing significant funding limitations compared to other areas of cancer research, the advancements we’ve seen in recent years are remarkable. New, targeted therapies offer hope to children who were once out of options. New discoveries are showing immense promise, and our understanding of the genetic underpinnings of childhood cancers is growing ever more profound.

However, we must not let these successes lull us into complacency. The struggle against childhood cancer is far from over. Too many children are still diagnosed with this devastating disease, and the long-term effects of treatment can be significant. We must ensure that every child can access the latest, most effective treatments, regardless of their background or zip code. Bridge To A Cure plays a vital role in this ongoing battle. Your continued support allows us to fund innovative research, advocate for better policies, and provide critical support services to families facing childhood cancer. Because of you, we can continue to outperform and make a real difference in the lives of thousands of brave children and their families. In the coming pages of this annual report, you’ll learn about the incredible impact your contributions are having and where our efforts are leading us in the future. Thank you for being a part of this vital mission. Together, we can create a future without the pain, suffering, and loss that cancer now bears on our children.

Robert Martin
Founder & President